Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Ocular Implants
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Ocular Implants Market By Product Type
1.2.2.1. Global Ocular Implants Market Revenue and Growth Rate Comparison By Product Type (2016-2027)
1.2.2.2. Global Ocular Implants Market Revenue Share By Product Type in 2019
1.2.2.2.1. Intraocular lenses
1.2.2.2.2. Corneal implants
1.2.2.2.3. Orbital implants
1.2.2.2.4. Glaucoma implants
1.2.2.2.5. Ocular prosthesis
1.2.2.2.6. Others
1.2.3. Ocular Implants Market By Application
1.2.3.1. Global Ocular Implants Market Revenue and Growth Rate Comparison By Application (2016-2027)
1.2.3.1.1. Glaucoma surgery
1.2.3.1.2. Oculoplasty
1.2.3.1.3. Drug delivery
1.2.3.1.4. Age-related macular degeneration
1.2.3.1.5. Aesthetic purpose
1.2.4. Ocular Implants Market By End-User
1.2.4.1. Global Ocular Implants Market Revenue and Growth Rate Comparison By End-User (2016-2027)
1.2.4.2. Hospitals
1.2.4.3. Eye Institutes
1.2.4.4. Specialty Eye Clinics
1.2.5. Ocular Implants Market By Geography
1.2.5.1. Global Ocular Implants Market Revenue and Growth Rate Comparison By Geography (2016-2027)
1.2.5.2. North America Ocular Implants Market Revenue and Growth Rate(2016-2027)
1.2.5.3. Europe Ocular Implants Market Revenue and Growth Rate(2016-2027)
1.2.5.4. Asia-Pacific Ocular Implants Market Revenue and Growth Rate(2016-2027)
1.2.5.5. Latin America Ocular Implants Market Revenue and Growth Rate(2016-2027)
1.2.5.6. Middle East and Africa (MEA)Ocular Implants Market Revenue and Growth Rate(2016-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Ocular Implants Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Ocular Implants Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Ocular Implants Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Ocular Implants Major Manufacturers in 2019
CHAPTER 4. OCULAR IMPLANTS MARKET BY PRODUCT TYPE
4.1. Global Ocular Implants Revenue By Product Type
4.2. Intraocular lenses
4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.3. Corneal implants
4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.4. Orbital implants
4.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.5. Glaucoma implants
4.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.6. Ocular prosthesis
4.6.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 5. OCULAR IMPLANTS MARKET BY APPLICATION
5.1. Global Ocular Implants Revenue By Application
5.2. Glaucoma surgery
5.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.3. Oculoplasty
5.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.4. Drug delivery
5.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.5. Age-related macular degeneration
5.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
5.6. Aesthetic purpose
5.6.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 6. OCULAR IMPLANTS MARKET BY END-USER
6.1. Global Ocular Implants Revenue By End-User
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.3. Eye Institutes
6.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.4. Specialty Eye Clinics
6.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
CHAPTER 7. NORTH AMERICA OCULAR IMPLANTS MARKET BY COUNTRY
7.1. North America Ocular Implants Market Revenue and Growth Rate, 2016 - 2027 ($Million)
7.2. North America Ocular Implants Market Revenue Share Comparison, 2016 & 2027 (%)
7.3. U.S.
7.3.1. U.S. Ocular Implants Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
7.3.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
7.4.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 8. EUROPE OCULAR IMPLANTS MARKET BY COUNTRY
8.1. Europe Ocular Implants Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. Europe Ocular Implants Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.3.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.4.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.5.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.6.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
8.7.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 9. ASIA-PACIFIC OCULAR IMPLANTS MARKET BY COUNTRY
9.1. Asia-Pacific Ocular Implants Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Asia-Pacific Ocular Implants Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.3.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.4.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.5.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.6.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.7.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
9.8.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 10. LATIN AMERICA OCULAR IMPLANTS MARKET BY COUNTRY
10.1. Latin America Ocular Implants Market Revenue and Growth Rate, 2016 - 2027 ($Million)
10.2. Latin America Ocular Implants Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.3.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.4.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
10.5.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 11. MIDDLE EAST & AFRICA OCULAR IMPLANTS MARKET BY COUNTRY
11.1. Middle East & AFRICA Ocular Implants Market Revenue and Growth Rate, 2016 - 2027 ($Million)
11.2. Middle East & AFRICA Ocular Implants Market Revenue Share Comparison, 2016 & 2027 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.3.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.4.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
11.5. Rest of Middle East & AFRICA
11.5.1. Market Revenue and Forecast By Product Type, 2016 - 2027 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2016 - 2027 ($Million)
11.5.3. Market Revenue and Forecast By End-User, 2016 - 2027 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Pfizer Inc
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Alcon
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. OSD Medical GmbH
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Novartis AG
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Staar Surgical
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. ZEISS International
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Bausch & Lomb Incorporated
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Johnson & Johnson Services, Inc
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Morcher GmbH
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Ophtec BV
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Others
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Type Portfolio
12.11.5. Key Developments
12.11.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
The increasing geriatric population, the rising cases of cataract formation, which is primarily in patients older than 65, is the leading factor to the growth of the ocular implant market.
The global ocular implants market size is expected to reach of around US$ 21,700 Mn by 2027.
The global ocular implants market is anticipated to grow at a CAGR of around 7% in terms of revenue during the forecast period 2020 – 2027.
North America accounted for major market share and also dominates the growth of ocular implant market due to increasing number of market vendors to expand their product portfolio in the region.
Major players included in this report Pfizer Inc., Alcon, OSD Medical GmbH, Novartis AG, Staar Surgical, ZEISS International, Bausch & Lomb Incorporated., Johnson & Johnson Services, Inc., Morcher GmbH, Ophtec BV, and others.
Intraocular lenses, Corneal implants, Orbital implants, Glaucoma implants, Ocular prosthesis and Others are the product types of ocular implant market.
Glaucoma surgery, Oculoplasty, Drug delivery, Age-related macular degeneration, and Aesthetic purpose are the applications of ocular implant market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date